The Yale School of Public Health is partnering with Nazarbayev University’s School of Medicine to launch the MoVE-Kaz advanced research training program, QazMonitor reports citing Nazarbayev University’s press service.
The program will support scientists and clinicians with an interest in virus phylogeny and molecular epidemiology, equipping them with crucial skills to investigate HIV spread in Central Asia, with a focus on high-risk communities.
With a 133% increase in the estimated number of people living with HIV infection in Kazakhstan from 2010 to 2020, experts underline the need to address the lack of healthcare access for those with HIV. MoVE-Kaz aims to improve HIV disease surveillance and treatment options through enhanced knowledge of resistance patterns in the region.
The goal of the training program is to create a pool of highly skilled Kazakh scientists and clinicians with expertise in phylogenetic applications, mentored by both national and international mentors from partner institutions like Asfendiyarov Kazakh National Medical University, Katholieke Universiteit Leuven in Belgium, and State University of New York (SUNY).
Scheduled to commence in early 2024, the full training program will be based at Nazarbayev University School of Medicine, but participants will have an opportunity to go through a three-month virology training program in New Haven. Additionally, the Fogarty grant will facilitate learning opportunities at KU Leuven in Belgium for researchers interested in statistical genetics and computational biology.